Nerve Sheath Neoplasms - 21 Studies Found

Completed : R115777 to Treat Children With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
:
  • Neurofibroma, Plexiform
  • Neurofibromatosis Type I

: 2006-06-19
:
  • Drug: tipifarnib Given orally,
Completed : Sorafenib to Treat Children and Young Adults With Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas
:
  • Neurofibromatosis Type I
  • Plexiform Neurofibroma

: 2008-07-31
:
  • Drug: Nexavar (BAY 43-9006) (Sorafenib)
  • Dr
Completed : Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
:
  • Neurofibromatosis 1
  • Neurofibroma, Plexiform

: 2004-01-13
: Drug: Pirfenidone Pirfenidone orally as capsules three times a day approximately every 8 hours for cycle
Completed : Study of Tasigna®/Nilotinib (AMN107) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas
:
  • Neurofibromatosis
  • NF1
  • Neurofibromas<
    : 2011-01-11
    : Drug: Tasigna Following enrollment each subject will initially receive Tasigna orally at 200 mg twice da
Recruiting : Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas That Cannot Be Removed by Surgery
:
  • Neurofibromatosis Type 1
  • Plexiform Neurofibroma

: 2015-04-02
:
  • Other: Laboratory Biomarker Analysis

Recruiting : Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (PNs)
:
  • Neurofibromatosis 1
  • Plexiform Neurofibromas

: 2015-09-05
Recruiting : Targeting the Mechanisms Underlying Cutaneous Neurofibroma Formation in NF1: A Clinical Translational Approach.
:
  • Cutaneous Neurofibromas
  • Neurofibromatosis Type 1
  • : 2015-01-21
    : Procedure: Skin Biopsy The procedure to sample the cutaneo
Suspended : Study of Sutent®/Sunitinib (SU11248) in Subjects With NF-1 Plexiform Neurofibromas
:
  • Neurofibromatosis
  • NF1
  • Plexiform Neur
    : 2011-07-25
    : Drug: Sutent®/Sunitinib Upon enrollment, subjects will receive Sutent® orally. Adults (Age >
Active, not recruiting : AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine
:
  • Neurofibromatosis Type 1
  • Plexiform Neurofibroma
  • : 2006-05-16
    : Drug: Cediranib Maleate Other Names:
    • AZD2171
    • AZD2171 Maleate
Recruiting : Acceptance and Commitment Training for Adolescents and Young Adults With Neurofibromatosis Type 1, Plexiform Neurofibromas, and Chronic Pain
:
  • Neurofibromatosis Type 1
  • Plexiform Neurofibromas

: 2015-06-12
: Other: Acceptance and Commitment Therapy (ACT) Acceptance and Commitment Therapy (ACT), a newer generati
<<< Previous | Next >>>